Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. IV: CAR-T cell therapy for multiple myeloma patients

Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. IV: CAR-T cell therapy for multiple myeloma patients

Extraordinary progress has been made over the last decade in the treatment of multiple myeloma with the incorporation of new drugs, particularly proteasome inhibitors, immunomodulators, and monoclonal antibodies.The combined use of innovative drugs, already in the first lines of treatment, has led t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Angelo Maiolino, Luciano J. Costa, Marcelo Pasquini, Edvan de Queiroz Crusoe, Afonso Celso Vigorito, Marco Aurélio Salvino, Fernanda Salles Seguro, Jayr Schmidt Filho, Vania Tietsche de Moraes Hungria
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Multiple myeloma
Treatment
Immunotherapy
CAR-T cells
Diseases of the blood and blood-forming organs
RC633-647.5
Acceso en línea:https://doaj.org/article/6b4eb551c30a469fa37f117d2387670c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/6b4eb551c30a469fa37f117d2387670c

Ejemplares similares